Fine Foods & Pharmaceuticals N.T.M. S.p.A.

DB:9S5 Stock Report

Market Cap: €194.4m

Fine Foods & Pharmaceuticals N.T.M Balance Sheet Health

Financial Health criteria checks 5/6

Fine Foods & Pharmaceuticals N.T.M has a total shareholder equity of €130.5M and total debt of €56.4M, which brings its debt-to-equity ratio to 43.2%. Its total assets and total liabilities are €232.0M and €101.4M respectively. Fine Foods & Pharmaceuticals N.T.M's EBIT is €15.2M making its interest coverage ratio 4.7. It has cash and short-term investments of €9.1M.

Key information

43.2%

Debt to equity ratio

€56.44m

Debt

Interest coverage ratio4.7x
Cash€9.06m
Equity€130.55m
Total liabilities€101.41m
Total assets€231.96m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 9S5's short term assets (€91.7M) exceed its short term liabilities (€62.3M).

Long Term Liabilities: 9S5's short term assets (€91.7M) exceed its long term liabilities (€39.2M).


Debt to Equity History and Analysis

Debt Level: 9S5's net debt to equity ratio (36.3%) is considered satisfactory.

Reducing Debt: 9S5's debt to equity ratio has increased from 21.1% to 43.2% over the past 5 years.

Debt Coverage: 9S5's debt is well covered by operating cash flow (74.1%).

Interest Coverage: 9S5's interest payments on its debt are well covered by EBIT (4.7x coverage).


Balance Sheet


Discover healthy companies